Don't mind Spicer, he hazes newbies. He's been on solagran for years and by the sounds the sauce for more years. I remember from my own psshead days, it leads to rapid mood swings and paranoia.
I am quite keen to hear more of why you believe SLA to be the one place to invest (just that to concentrate all your resources on this one play shows confidence in them). What was the previous mob you were on for 8 years, what about them (more specifics) lead you to ditch?
You are right to wonder if Dr Agishev has a vested interest. You will have noticed there are alot of possibly-confusing relationships in the solagran story. SLA Owning 25% of BPO has nothing to do with "Gun" Khourie? And former creditor now largest shareholder Solana has nothing to do with Solamind...
There has been alot of posts here and elsewhere asserting that the ropren drug trials did not have sufficient sample sizes to be statistically robust. A mistrust of Russian academic standards, where there is quite the industry in ghost-written PhDs paid for by up and coming apparatchiks, might not be out of place. Our mate Vladimir Putin may be one former customer of such an industry.
I'm not saying that Dr Agishev got his qualifications out of a wheaties box. He'd have to know at least a bit about psychiatric medicine to stay director for 20 years. But he'd also have to be very adept at hospital and scientific politics to stay in that position for 20 years.
Doctors the world over know the power they wield over pharma companies. I personally don't mind how many palms have to get greased or how many ticks this dog has got. If the reality for ropren sales is even 5% of the hype then there's gonna be bucketloads of cash to go around.
I don't mind that Dr Diedre O'Neill is the 10th biggest shareholder of SLA in last top-20 I saw, at the same time as there is a (small, local) boom in Ropren sales in NZ. It is natural to distrust sales that are not occuring in a transparent marketplace. But it pays to accumulate powerful friends.
There was a ramble that went nowhere. Go SLA!
SLA Price at posting:
30.8¢ Sentiment: LT Buy Disclosure: Held
